Literature DB >> 6970998

[A new antianginal drug, bepridil: efficacy estimation by exertion test during a double blind test against a placebo (author's transl)].

J C Canicave, J Deu, J Jacq, R Paillet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6970998

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  5 in total

1.  Studies on the bradycardia induced by bepridil.

Authors:  M Beaughard; M Ferrier; C Labrid; J C Lamar; J Leboeuf; P Piris
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

2.  A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation.

Authors:  M S Perelman; W J McKenna; E Rowland; D M Krikler
Journal:  Br Heart J       Date:  1987-10

3.  Electrophysiological action of bepridil on atrioventricular accessory pathways.

Authors:  P Touboul; G Atallah; G Kirkorian; P Lavaud; J R Kieny; M P Mathieu; A Dellinger
Journal:  Br Heart J       Date:  1987-10

4.  Comparative clinical efficacy of bepridil, propranolol and placebo in patients with chronic stable angina.

Authors:  A P Rae; J M Beattie; T D Lawrie; I Hutton
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

5.  Myocardial infarction: is bepridil, a new calcium antagonist, able to improve the course of the acute phase?

Authors:  D Flammang; M Waynberger; R Paillet; C Pruvot; G Cosson; A Chassing
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.